Groupama Asset Management’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$5.64M Sell
21,959
-734
-3% -$171K 0.07% 100
2026
Q1
$5.55M Sell
22,693
-11,091
-33% -$2.58M 0.08% 99
2025
Q4
$6.99M Sell
33,784
-2,935
-8% -$580K 0.1% 95
2025
Q3
$6.81M Sell
36,719
-2,495
-6% -$427K 0.1% 93
2025
Q2
$5.98M Buy
39,214
+4,777
+14% +$734K 0.1% 100
2025
Q1
$5.64M Sell
34,437
-7,455
-18% -$1.17M 0.11% 97
2024
Q4
$6M Sell
41,892
-9,542
-19% -$1.48M 0.12% 103
2024
Q3
$6.69M Sell
51,434
-5,420
-10% -$864K 0.17% 88
2024
Q2
$8.31M Buy
56,854
+24,002
+73% +$3.57M 0.11% 103
2024
Q1
$10.1M Buy
32,852
+32,224
+5,131% +$5.13M 0.18% 97
2023
Q4
$98.5K Buy
+628
New +$96.3K ﹤0.01% 401

Other funds holding JNJ

Groupama Asset Management's JNJ Position: Q2 2026 in Review

Groupama Asset Management reduced its Johnson & Johnson (JNJ) stake by 3.2% in Q2 2026, selling an estimated $171K and leaving 21,959 shares worth $5.64M. The position accounts for 0.07% of the portfolio, ranked #100.

Groupama Asset Management first reported a position in JNJ in Q4 2023 and has held it in 11 quarters since. The position peaked at $10.1M in Q1 2024. 4,672 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • Groupama Asset Management held 21,959 shares of Johnson & Johnson worth $5.64M as of Q2 2026.
  • Groupama Asset Management sold 734 Johnson & Johnson shares in Q2 2026, an estimated $171K.
  • Johnson & Johnson made up 0.07% of Groupama Asset Management's portfolio in Q2 2026, its #100 holding.
  • Groupama Asset Management first reported a position in Johnson & Johnson in Q4 2023 and has held it in 11 quarters since.
  • Groupama Asset Management's Johnson & Johnson position peaked at $10.1M in Q1 2024.
  • 4,672 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on Groupama Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.